Skip to content
S8880Senate2023-2024 SessionSame asA1010

Stop Hiding Drug Labels

Official title

“Prohibits label obstruction of over-the-counter drugs or cosmetics”

Sponsor James Sanders Jr.SD-10Affects Public Safety & Consumer Affairs
Status
Senate Floor Calendar
Impact
6/10
Moderate
Outcome
Companion signed

Bill progress

Signed via A1010

What's happening

This bill prohibits retailers from selling or altering labels of expired or label-obstructed over-the-counter drugs and cosmetic products.

Why it matters

  1. Expands consumer protection. by including cosmetics alongside over-the-counter drugs, meaning products like deodorant, shampoo, and conditioner are now covered by the law—helping ensure consumers aren’t unknowingly buying potentially unsafe or ineffective items.

  2. Targets deceptive retail practices. by making it illegal not only to sell expired products, but also to alter, obscure, or remove any part of a product’s label (including expiration dates), closing loopholes where expiration information could be hidden with price stickers or other methods.

  3. Aligns state regulations with federal standards. by defining “label” based on FDA rules, which could help standardize enforcement and clarify expectations for retailers and manufacturers.

  4. Promotes transparency and safety. by requiring products to be clearly marked and by penalizing attempts to hide expiration or product information, which can reduce health risks and improve trust for consumers shopping for non-prescription drugs and personal care items.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Drugstores and other retailers

    The bill would prohibit knowingly obstructing or altering any part of over-the-counter drug or cosmetic labels or packaging, including with price stickers.

  • Cosmetics retailers

    The bill would extend the ban on knowingly selling expired over-the-counter drugs to cosmetics, including deodorant, shampoo and conditioner.

  • Shoppers buying over-the-counter drugs and cosmetics

    The bill would protect access to unobstructed labels and packaging, including expiration dates where applicable.

Headline styles

Stop Hiding Drug Labels

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Sanders Jr.

Senator · Senate District 10

Chair, Banks

No co-sponsors yet.

History

  1. Substituted by A1010B
  2. Ordered to third reading cal.1774
  3. Committee discharged and committed to rules
  4. Print number 8880a
  5. Amend and recommit to consumer protection
  6. Referred to consumer protection

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A1010Assembly

No Label Obstruction on Medicines

Signed by Governor · Sponsor David Weprin

Impact 6 · ModerateSigned into law

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8880--A

IN SENATE

March 25, 2024

Introduced by Sen. SANDERS -- read twice and ordered printed, and when printed to be committed to the Committee on Consumer Protection -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the general business law, in relation to the sale of over-the-counter drugs and cosmetic products

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The article heading of article 38-A of the general business law, as added by chapter 697 of the laws of 1986, is amended to read as follows:

SALE OF OUTDATED

AND LABEL OBSTRUCTED OVER-THE-COUNTER DRUGS AND

COSMETIC PRODUCTS

§ 2. Section 820 of the general business law, as added by chapter 697 of the laws of 1986, is amended to read as follows:

§ 820. Unlawful practices. 1. It shall be unlawful for any retailer:

[1.] (a) to knowingly sell or offer for sale, any drug or cosmetic sold over-the-counter without the need of a prescription, later than the date, if any, marked upon the label as indicative of the date beyond which the contents cannot be expected beyond reasonable doubt to be safe and effective; provided, however, that when such drug or cosmetic is identified as an outdated drug or cosmetic by segregation from regular stock or by other means, the holding of such drug or cosmetic beyond its expiration date shall not be deemed a violation of this section. When the expiration date is expressed by month and year, the expiration date shall be the last day of the month indicated; or

[2.] (b) to knowingly alter, mutilate, destroy, obliterate, obstruct or remove by means of a price sticker or otherwise the whole or any part of [the expiration date displayed on] the label or packaging, including, where applicable, the expiration date displayed thereon, of any overthe-counter drug or cosmetic.

2. For purposes of this section, the following terms shall have the following meanings:

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD01243-05-4

(a) "label" shall mean the label required by the statutes applicable to and regulations issued by the federal food and drug administration; and

(b) "cosmetic" shall mean articles intended to be rubbed, poured, sprinkled or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, including but not limited to personal hygiene products such as deodorant, shampoo or conditioner.

§ 3. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the general business law, in relation to the sale of over-the-counter drugs and cosmetic products

Purpose

To promote and protect the health and safety of purchasers of O-T-C drugs and cosmetics by enabling them to read such products' packaging or labels in a complete, unaltered and unobstructed condition, at the time of purchase or thereafter. Such labels are required by federal law and regulations.

Summary of provisions

Section 1. Changes the article heading of Article 38-A of the General Business law.

Read the full memo (903 words)

Section 2. Amends subdivisions 1 and 2 of Section 820 of the General Business law, to make it unlawful for any retailer to knowingly alter, obstruct, obscure or remove, by means of a sticker, tag or other device used to deter theft, or a price sticker, or otherwise, the whole or any part of the label or packaging of any over-the-counter (0-T-C) drug or cosmetic as such label is required by the federal Food, Drug and Cosmet- ic Art, and by the Food and Drug Administration's (FDA) rules and regu- lations that implement the Act's label requirements for such products. Violators would be subject to the existing enforcement remedy contained in GBL, Section 821. Under that provision, compliance with FDA rules and regu- lations constitutes a complete defense to any enforcement action. Also adds a new subdivision 3 to the section providing definitions for label and cosmetic.

Justification

At the very foundation of consumer protection for purchasers of 0-T-C drugs and cosmetics are the labeling requirements of Chapters V and VI of the Federal Food, Drug and Cosmetic Act and the implementing regu- lations of the Food and Drug Administration. (See 21 C.F.R. Part 201, Subchapter C, et seq. (0-T-C drugs) and 21 FR Part 701 cosmetics). Drug labels provide vital health and safety information including indi- cations, directions for use, warnings and precautions, drug interaction information, cautions and list of ingredients. Cosmetic labels must contain a designation of ingredients, a requirement of special impor- tance for users who suffer particular allergic reactions.

In early 1920, the Department of Law's Bureau of Consumer Frauds and Protection conducted a random survey of drug stores operated by eight major chains located in the metropolitan New York City area in an effort to determine whether the labels of O-T-C drugs or cosmetics offered for sale to the public were being obscured or obstructed by the retailers' practice of superimposing upon such labels the store's own price stick- ers or security stickers or other devices intended to deter theft. The survey revealed that in a significant number of instances, retailers were obstructing or obscuring product labels by placing paper stickers or plastic devices over the manufacturer's product labels. This practice made it impossible, in many cases, for prospective purchasers to read the labels before purchase. Even after purchase, consumers, in many cases, would be unable to read the labels because the removal of the retailer's stickers would result in the unintended destruction of the manufacturer's label as well. Indeed, in one case, the cashier at a major drug retail chain store tore off the store's sticker from the principal display panel of an O-T-C drug product and, in doing so, destroyed the manufacturer's label at the same time. In general, this practice could have severe health and safety consequences. For example, the product in question in this particular case was "Colly rium Fresh Sterile Eye Drops" manufactured by Wyeth Laboratories. That part of the manufacturer's label destroyed by the store's cashier included crucial product warnings and cautions, as follows:

Warnings: Do not use if solution changes color or becomes cloudy. Remove contact lenses before using if you have glaucoma do not use this product except under the advice and supervision of a physician. Overuse of this product may produce increased redness of the eye. To avoid contamination, do not touch tip of container to any surface. Replace cap after using. If you experience eye pain, changes in vision, contin- ued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physi- cian. Keep this and all medication out of the reach of children. Retain this carton for complete product information. Keep bottle lightly closed at Room Temperature; Approx. 77 degrees F/25 degrees C.

The Department of Law survey confirmed that the above-described practice by retail drug stores is common and widespread. Case by case enforcement would not offer consumers the full protection that a legislative initi- ative offers. This bill builds upon an earlier law that addressed a related problem. In 1985, a survey published by the Department of Law revealed, inter aide, that retailers of O-T-C drugs were similarly obstructing the expiration date of such drug products offered for sale. (See Expiration. Dating of Over-TheCounter Drugs in New York, a report by New York State Attorney General Robert Abrams (January 1985)). Subse- quently, the Legislature adopted an Attorney General's Program bill (1986, Ch. 697) that included GBL Section 820(2), a provision that makes such practice unlawful. The present proposal would offer parallel protection for consumers with regard to the obstruction of labels.

LEGISLATIVE HISTORY:.

2023: referred to rules

2021/2022: referred to consumer affairs and protection

2019/2020: referred to consumer affairs and protection

2017/2018: referred to consumer affairs and protection

Fiscal implications

None.

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.